{
    "organizations": [],
    "uuid": "e80300b8e9fea75417e65511f7422a9a4a2770ca",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-epigenomics-cumulative-loss-of-mor/brief-epigenomics-cumulative-loss-of-more-than-half-of-nominal-share-capital-idUSFWN1RU18M",
    "ord_in_thread": 0,
    "title": "BRIEF-Epigenomics: Cumulative Loss Of More Than Half Of Nominal Share Capital",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 17 (Reuters) - Epigenomics AG:\n* NOTIFIES A CUMULATIVE LOSS OF MORE THAN HALF OF NOMINAL SHARE CAPITAL OF COMPANY HAS BEEN INCURRED\n* CURRENT FINANCIAL RESOURCES OF COMPANY ARE SUFFICIENT TO SUPPORT OPERATIONS BEYOND 2018\n* EXECUTIVE BOARD EXPECTS TO BE ABLE TO RAISE ADDITIONAL CAPITAL IN 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-18T00:33:00.000+03:00",
    "crawled": "2018-04-18T18:21:16.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "epigenomics",
        "ag",
        "notifies",
        "cumulative",
        "loss",
        "half",
        "nominal",
        "share",
        "capital",
        "company",
        "incurred",
        "current",
        "financial",
        "resource",
        "company",
        "sufficient",
        "support",
        "operation",
        "beyond",
        "executive",
        "board",
        "expects",
        "able",
        "raise",
        "additional",
        "capital",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}